Dados B3 › BPHA3 × DASA3
BPHA3 × DASA3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | BPHA3 | DASA3 | year |
|---|---|---|---|
| ROE | -149.5% | 3.4% | 2016 |
| ROIC | -348.5%! | 6.2% | 2017 |
| ROA | 966.4%! | 2.8% | 2018 |
| Gross margin | 98.3%! | 35.5% | 2018 |
| EBIT margin | -302.4%! | 8.8% | 2018 |
| Net margin | 10,996.5%! | 4.7% | 2018 |
| Net debt/EBITDA | 19.79x | 1.99x | 2013 |
| Current ratio | 0.06x! | 1.63x | 2018 |
| Revenue growth (1y) | -17.5%! | 15.7% | 2018 |
| Revenue growth (5y CAGR) | -68.9%! | 10.0% | 2018 |
| Piotroski F-Score | 5/9! | 7/9 | 2018 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | BPHA3 | DASA3 | year |
|---|---|---|---|
| P/E | 0.15x | -3.70x | 2018 × 2025 |
| P/B | — | 0.62x | 2018 × 2025 |
| EV/EBITDA | — | 4.56x | 2018 × 2025 |
| FCF yield | -55.2% | -7.7% | 2018 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:45 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:45 UTC. If this does not match /saude, you are reading a cached copy.